New research indicates that people who discontinue new weight-loss injections like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who end traditional lifestyle regimens.
Findings released in a prominent health publication points out that while obese individuals often shed a large proportion of their body weight while using the jabs, the weight returns at an average rate of 0.8 kg per month upon discontinuation.
"Individuals using these drugs must be aware of the potential of quick rebound weight gain when the therapy concludes," warns lead investigator Dr. Susan Jebb.
That rate of regain implies a reversion to starting weight within about one and a half years.
Analyzing Treatments
The research, which reviewed 37 of studies involving thousands of participants, compared the outcomes of GLP-1 agonists with other pills.
Researchers note that people who shed pounds through diet and exercise typically experience a slower creep back—approximately 100 grams monthly—once they finish.
Explaining the Rapid Regain
Experts suggest the mechanism of the drugs accounts for the heightened regain.
These medications copy a natural hormone called GLP-1, which controls hunger.
"Long-term administration of the hormone concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous hormone, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Stopping of this GLP-1 'fix' results in hunger is uncontrolled, making overeating a significant risk."
A Lifelong Disease?
Medical guidelines advise the jabs for people with obesity-related health risks, alongside recommended diet and exercise modifications.
A number of clinicians contend that, due to the high risk of relapse, the treatment might need to be ongoing.
This perspective is supported by pharmaceutical companies, who note that the results "underscore the persistent character of obesity," akin to managing diseases like high blood pressure.
Patient Experiences
People who have come off the jabs explain a intense return of cravings.
"I experienced a switch activating and you're instantly extremely hungry," described an individual.
The struggle is exacerbated if users have not established lasting lifestyle or habit modifications during treatment.
Widespread Adoption
Recent estimates indicate that millions of adults in the UK have used weight-loss jabs in the past year, with desire continuing to grow.
- Use is higher among females compared to men.
- The middle-aged age group shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than the NHS.
Finally, experts emphasize that while GLP-1 drugs are potent tools for weight loss, they are not a permanent fix and long-term success relies on integrated lifestyle changes.